Biodesix Announces Closing of New $30 Million Term Loan

24 Mar, 2021

Biodesix Announces Closing of New $30 Million Term Loan
Photo by Piotr Wilk on Unsplash

– Biodesix, Inc. (NASDAQ: BDSX; “Biodesix” or the “Company”) a leading data-driven diagnostic solutions company with a focus in lung disease, announced today that it has closed on a new $30 million term loan (New Term Loan) which matures on March 1, 2026.
– The proceeds were used to repay outstanding borrowings of $25.9 million under the Company’s existing term loan with Innovatus Life Sciences Lending Fund I, LP (Innovatus), which was terminated upon payment, and the remaining proceeds of approximately $4 million will enhance existing liquidity for general corporate purposes.

Biotechnology Health Diagnostics Medical North America
Crunchbase icon

Content report

The following text will be sent to our editors: